Delaplex Limited has secured approval from the National Stock Exchange of India Limited to list and trade 48,480 equity shares allotted under its Delaplex Employees Stock Option Scheme, 2024. These shares, carrying a face value of ₹10 each, will be available for trading starting June 25, 2026. The approval follows the exercise of stock options by employees under the company's ESOS 2024.

The equity shares approved for listing fall under the 'SM' series on the NSE. The distinctive numbers for these shares range from 9110001 to 9158480. There is no lock-in period applicable to these shares, allowing for immediate trading upon listing.

Details of Listed Shares

The following table outlines the specific batches of shares approved for listing:

The intimation was submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company Secretary cum Compliance Officer, CS Manishraj Bhatt, confirmed the receipt of the listing approval from the exchange.

Delaplex Limited reported a consolidated net profit of ₹721.77 lakh for the half-year ended September 30, 2025, driven by a rise in revenue from operations to ₹3,717.75 lakh. The company's Board of Directors approved the standalone and consolidated unaudited financial results for the period on November 14, 2025, confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The financial performance reflects a total income of ₹3,903.38 lakh for the consolidated entity. On a standalone basis, the company recorded a net profit of ₹495.11 lakh on revenue from operations of ₹3,057.75 lakh. Jodh Joshi and Co., Chartered Accountants, issued a limited review report stating that nothing came to their attention to suggest the results contained material misstatements.

Financial Highlights

The following table outlines the key financial metrics for the half-year ended September 30, 2025, compared to the previous period:

IPO Proceeds Utilization

The company submitted a statement confirming there were no deviations or variations in the utilization of Initial Public Offer (IPO) proceeds during the half-year ended September 30, 2025. The total amount raised through the IPO was ₹46,08,00,000, comprising a fresh issue of ₹34,56,00,000 and an offer for sale of ₹11,52,00,000. The Audit Committee reviewed the utilization and confirmed that funds were used for the purposes stated in the prospectus.

The disclosure regarding the utilization of issue proceeds was submitted in the format prescribed by SEBI. The company also clarified that comparative figures in the financial statements have been disclosed in compliance with Schedule III of the Companies Act, 2013 and Indian Accounting Standards.

Auditor's Declaration

Pursuant to Regulation 33(3)(d) of the SEBI Listing Regulations, Delaplex declared that the auditor's report on the standalone and consolidated financial statements is unmodified and without any qualification. The statutory auditor, Jodh Joshi and Co., holds a valid peer review certificate issued by the Peer Review Board of ICAI.